本頁面由Tiger Trade Technology Pte. Ltd.提供服務

ANI Pharmaceuticals, Inc.

75.39
+1.802.45%
盤後75.390.00000.00%19:30 EDT
成交量:58.60萬
成交額:4,400.87萬
市值:17.32億
市盈率:16.61
高:75.67
開:73.68
低:73.54
收:73.59
52周最高:98.55
52周最低:69.58
股本:2,297.04萬
流通股本:2,028.20萬
量比:1.58
換手率:2.89%
股息:- -
股息率:- -
每股收益(TTM):4.54
每股收益(LYR):3.32
淨資產收益率:20.46%
總資產收益率:5.45%
市淨率:2.90
市盈率(LYR):22.71

資料載入中...

2023/09/08

重要事件披露

Form 8-K - Current report
2023/08/30

重要事件披露

Form 8-K - Current report
2023/08/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/23

重要事件披露

Form 8-K - Current report
2023/08/18

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/08/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/09

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/09

重要事件披露

Form 8-K - Current report
2023/07/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/07/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/07/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/07/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities